Saving production timelines
“When one of our key suppliers discontinued a pharmaceutical excipient, it created a ripple effect we had to contain quickly,” begins Fernanda Macarini, Product Development Specialist - Pharma at Caldic LATAM. “Our customer suddenly had no access to a critical component in their formulation, and the available alternative wasn’t ready.”
Excipients are essential for the stability and delivery of drugs. A substitute cannot just match specifications on paper; it has to pass rigorous quality tests, meet regulatory requirements, and perform exactly as the original in the final formulation.
Collaboration, testing, and technical precision
“That’s where our market knowledge and technical know-how came in,” Fernanda explains. “We immediately started working with the customer’s quality control team to analyze and adapt the starch-based excipient to fit their needs.”
The path wasn’t straightforward. “Early tests didn’t go well. Solubility, density, and viscosity were all off. It didn’t meet the product requirements, and that could have put their production at risk, but we supported the customer through the complex R&D and analytical qualification stages,” she says.